Valuation: Acme Resources Corp

Market Cap 12.28M 8.92M 8.92M 7.64M 7.15M 6.54M 853M 12.44M 84.45M 32.93M 429M 33.49M 32.76M 1.42B P/E 2025
-3.92x
P/E 2026 -5.88x
Enterprise Value 17.59M 12.77M 12.77M 10.94M 10.24M 9.37M 1.22B 17.82M 121M 47.17M 614M 47.97M 46.92M 2.03B EV / Sales 2025
11.8x
EV / Sales 2026 9.23x
Free-Float
82.98%
Yield 2025 *
-
Yield 2026 -
07-30 Rapid Dose Therapeutics Corp. Reports Earnings Results for the First Quarter Ended May 31, 2026 CI
07-29 Rapid Dose Therapeutics Corp And Bodhi Health Inc Expand Distribution And Sales Of CurcuWIN QuickStrip Curcumin Across Canada CI
07-06 Rapid Dose Therapeutics Corp. and Global Nicotine Leader Extend Strategic Collaboration for Quickstrip Dissolvable Oral Nicotine Strip Technology CI
06-29 Rapid Dose Therapeutics Corp. Reports Earnings Results for the Full Year Ended February 28, 2026 CI
06-28 Rapid Dose Therapeutics Corp. Auditor Raises 'Going Concern' Doubt CI
04-13 Rapid Dose Therapeutics Corp Advances Pharmaceutical Manufacturing Expansion with Burlington Facility Upgrades Targeting Global Medical Markets CI
04-06 Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt MT
03-05 Rapid Dose Therapeutics And Aavishkar Oral Strips Secure Patent For Quickstrip Nicotine Bilayer Oral Film CI
02-23 Rapid Dose Therapeutics Corp. Advances Cannabinoid Research and Clinical Evaluation of QuickStrip Platform CI
02-10 Rapid Dose Therapeutics Corp. Launches QuickStrip? Medical Cannabis for Patients in Brazil CI
01-29 Rapid Dose Therapeutics Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended November 30, 2025 CI
25-10-30 Rapid Dose Therapeutics Corp. Reports Earnings Results for the Second Quarter and Six Months Ended August 31, 2025 CI
25-08-05 Rapid Dose Therapeutics Corp. Submits QuickStrip®? Nicotine Product for Health Canada CI
Manager TitleAgeSince
Chief Executive Officer - 2017-05-02
Director of Finance/CFO - 2020-02-27
Corporate Officer/Principal - 2019-12-05
Director TitleAgeSince
Chairman - -
Director/Board Member - 2024-08-05
Director/Board Member - 2020-08-12
Change 5-day change 1-year change 3-year change Capi.($)
+13.01%+0.69%-29.54%-41.39% 122M
+3.01%+4.81%+115.77%+52.06% 93.47M
-2.22%-2.35%-15.75%-64.74% 89.74M
0.00%-5.71%+40.38%-27.07% 59.57M
Average +3.45%-0.64%+27.71%-20.29% 91.22M
Weighted average by Cap. +4.58%-0.05%+22.49%-20.86%

Financials

2025 2026
Net sales 2.09M 1.51M 1.51M 1.3M 1.21M 1.11M 145M 2.11M 14.34M 5.59M 72.79M 5.69M 5.56M 241M 2.77M 2.01M 2.01M 1.73M 1.61M 1.48M 193M 2.81M 19.07M 7.44M 96.81M 7.56M 7.4M 320M
Net income -5.4M -3.92M -3.92M -3.36M -3.15M -2.88M -376M -5.48M -37.17M -14.49M -189M -14.74M -14.42M -624M -3.39M -2.46M -2.46M -2.11M -1.97M -1.81M -236M -3.43M -23.31M -9.09M -118M -9.24M -9.04M -391M
Net Debt 2.59M 1.88M 1.88M 1.61M 1.51M 1.38M 180M 2.62M 17.81M 6.94M 90.38M 7.06M 6.91M 299M 5.31M 3.86M 3.86M 3.3M 3.09M 2.83M 369M 5.38M 36.52M 14.24M 185M 14.48M 14.16M 613M
Logo Acme Resources Corp
Rapid Dose Therapeutics Corp. is a Canadian biotechnology company. It provides disruptive drug delivery technologies designed to improve patient outcomes. Its flagship product, QuickStrip, is a thin, orally dissolvable film that can be infused with an infinite list of active ingredients, including nutraceuticals, pharmaceuticals, and vaccines, that are delivered quickly into the bloodstream, resulting in rapid onset of the active ingredient. It has one operating segment comprising production, distribution, research, and the provision of technical services for the delivery of oral thin film strips containing active ingredients. It offers over-the-counter and pharmaceutical drug delivery solutions. Its QuickStrip Energy delivers energizing caffeine. Its QuickStrip B12 delivers vitamin B12 to the system, assisting with metabolism and physical energy. Its QuickStrip Sleep delivers melatonin to the system, inducing natural and healthy sleep. QuickStrip Lidocaine is its dental product.
Employees
-